A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT study-Reference-Cited by-同舟云学术

A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT study

Published:2021-05-31 Issue:10 Volume:56 Page:2454-2463
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Mohty Mohamad^ORCID,Battista Marta Lisa,Blaise Didier^ORCID,Calore Elisabetta,Cesaro Simone^ORCID,Maximova Natalia^ORCID,Perruccio Katia,Renard Cecile,Wynn Robert,Zecca Marco^ORCID,Labopin Myriam^ORCID,Hanvesakul Raj,Amber Vian,Ryan Robert J.,Lawson Sarah,Ciceri Fabio

Funder

Jazz Pharmaceuticals

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-021-01265-2.pdf

Reference24 articles.

1. Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A, et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transpl. 2010;16:157–68.

2. Corbacioglu S, Carreras E, Ansari M, Balduzzi A, Cesaro S, Dalle JH, et al. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transpl. 2018;53:138–45.

3. Dalle JH, Giralt SA. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: risk factors and stratification, prophylaxis, and treatment. Biol Blood Marrow Transpl. 2016;22:400–9.